Chimerix to Announce Third Quarter 2015 Financial Results on November 5, 2015
DURHAM, N.C., Oct. 29, 2015 (GLOBE NEWSWIRE) -- Chimerix, Inc. (Nasdaq:CMRX), a biopharmaceutical company developing novel, oral antivirals in areas of high unmet medical need, today announced that it will report financial results for the third quarter …